What question did this study set out to answer?

The aim is to integrate time-varying pharmacometric models with Cox regression to improve analyses of time-to-event endpoints.

Integration of Time‐Varying Pharmacometric Modeling With Cox Regression for Time‐to‐Event Analysis in NONMEM

View Full Paper

Ask AI

Bookmark

Authors

Randomized trial integrates time-varying pharmacometric modeling with Cox regression, enhancing time-to-event analyses for drug development.

The aim is to integrate time-varying pharmacometric models with Cox regression to improve analyses of time-to-event endpoints.
Developed methodology using NONMEM for modeling time-varying effects on TTE endpoints.
Conducted clinical trial simulations with varying sample sizes and dose levels.
Estimated model parameters using partial likelihood and compared semi-parametric and parametric methods.
The semi-parametric approach provided robust estimates aligning with the correct baseline hazard assumption.
Time-varying exposure metrics outperformed static metrics in accuracy and predictive power.
The proposed integration enhances model-informed decision-making in drug development.

Lin et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark

Randomized trial integrates time-varying pharmacometric modeling with Cox regression, enhancing time-to-event analyses for drug development.